Literature DB >> 9826370

Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.

K Eriksson1, M Quiding-Järbrink, J Osek, A Möller, S Björk, J Holmgren, C Czerkinsky.   

Abstract

To determine optimal strategies to induce specific-antibody-secreting cells (specific ASC) in the rectal and vaginal mucosae, we immunized monkeys with a prototype mucosal immunogen, cholera toxin (CT), given locally or via gastric or parenteral administration. Repeated rectal or vaginal CT immunizations induced strong mucosal and systemic ASC responses. The mucosal responses were, however, confined to the immunization sites and comprised high levels of both specific antitoxin immunoglobulin A (IgA) and IgG. Large numbers of specific IgA and IgG ASC were detected in cell suspensions from dissociated genital and rectal tissues, demonstrating local accumulation of effector B cells at these sites. Intragastric immunization with CT did not per se give rise to cervicovaginal or rectal ASC responses but did prime for a rectal IgA ASC response to local booster immunization. Both rectal and vaginal immunizations also induced circulating blood IgG ASC and IgA ASC. In conclusion, these results show that local administration of antigen to the rectal or vaginal mucosa results in higher ASC responses than systemic or distant mucosal delivery. Furthermore, both the vaginal and the rectal mucosae can serve as inductive sites for systemic ASC responses. These observations should be relevant to the development of vaccines against sexually transmitted diseases such as that caused by human immunodeficiency virus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826370      PMCID: PMC108746     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Active and passive sensitization of the uterus of the cow in vivo against Trichomonas foetus antigen and the evidence for the local production of antibody in that site.

Authors:  W R KERR; M ROBERTSON
Journal:  J Hyg (Lond)       Date:  1953-09

2.  Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers.

Authors:  M Jertborn; A M Svennerholm; J Holmgren
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

3.  Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.

Authors:  M B Mazanec; C L Coudret; D R Fletcher
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

4.  Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization.

Authors:  S J Czinn; A Cai; J G Nedrud
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

5.  Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

6.  Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis.

Authors:  F A Plummer; H Chubb; J N Simonsen; M Bosire; L Slaney; N J Nagelkerke; I Maclean; J O Ndinya-Achola; P Waiyaki; R C Brunham
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.

Authors:  R Weltzin; S A Hsu; E S Mittler; K Georgakopoulos; T P Monath
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

8.  Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.

Authors:  F M Apter; P Michetti; L S Winner; J A Mack; J J Mekalanos; M R Neutra
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections.

Authors:  K J Whaley; L Zeitlin; R A Barratt; T E Hoen; R A Cone
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

10.  Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.

Authors:  B Haneberg; D Kendall; H M Amerongen; F M Apter; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

View more
  21 in total

1.  Anatomic segmentation of the intestinal immune response in nonhuman primates: differential distribution of B cells after oral and rectal immunizations to sites defined by their source of vascularization.

Authors:  K Eriksson; M Quiding-Järbrink; J Osek; I Nordström; M Hjulström; J Holmgren; C Czerkinsky
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.

Authors:  E L Johansson; L Wassén; J Holmgren; M Jertborn; A Rudin
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Generation of female genital tract antibody responses by local or central (common) mucosal immunization.

Authors:  H Y Wu; S Abdu; D Stinson; M W Russell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 4.  Microneedle-Mediated Vaccine Delivery to the Oral Mucosa.

Authors:  Rachel L Creighton; Kim A Woodrow
Journal:  Adv Healthc Mater       Date:  2018-12-10       Impact factor: 9.933

5.  Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa.

Authors:  M Quiding-Järbrink; I Ahlstedt; C Lindholm; E L Johansson; H Lönroth
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

6.  Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.

Authors:  Davide Agnello; Christine A Hervé; Amandine Lavaux; Magali Darniot; Patrice Guillon; Annie Charpilienne; Pierre Pothier
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Actinobacillus pleuropneumoniae iron transport and urease activity: effects on bacterial virulence and host immune response.

Authors:  N Baltes; W Tonpitak; G F Gerlach; I Hennig-Pauka; A Hoffmann-Moujahid; M Ganter; H J Rothkötter
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

8.  HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model.

Authors:  Xiaofei Yan; Depu Wang; Fengli Liang; Ling Fu; Cheng Guo
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.

Authors:  Nicolas Cuburu; Mi-Na Kweon; Catherine Hervouet; Hye-Ran Cha; Yuk-Ying S Pang; Jan Holmgren; Konrad Stadler; John T Schiller; Fabienne Anjuère; Cecil Czerkinsky
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Mucosal vaccination increases endothelial expression of mucosal addressin cell adhesion molecule 1 in the human gastrointestinal tract.

Authors:  Catharina Lindholm; Andrew Naylor; Eva-Liz Johansson; Marianne Quiding-Järbrink
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.